ASSET
Published on ASSET (https://www.asset-scienceinsociety.eu)

Home > Taxonomy term

Decision Makers

The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations

Karafillakis E, Larson HJ; ADVANCE consortium. Vaccine. 2017 Jul 28.

Objectives:
The success of vaccination strategies depends in part on population perceptions of benefits and risks of vaccines and related confidence in vaccination. Better knowledge of public concerns about vaccines and what is driving them is needed to inform vaccination strategies and communications. This literature reviewer examined studies on vaccine and vaccination risk perceptions and concerns across European populations.

Target: 
Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Vaccination
Tags: 
Vaccine, Vaccine hesitancy, ​risk perception, Health communication, vaccination campaigns
  • Read more about The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations

Gender issues in chronic diseases and influenza vaccines

Monday, August 7, 2017 - 15:05

People with already existing conditions, such as cardiovascular diseases, diabetes, and pulmonary/respiratory disease, are at greater risk from influenza (Logue et al., 2011). Women are more likely to have diabetes in their lifetime than men, and studies in the US show that women, particularly those in lower socioeconomic groups, receive less adequate diabetes care than men from the same socioeconomic group (WHO, 2010).

  • Read more about Gender issues in chronic diseases and influenza vaccines
Target: 
Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Epidemiology, Gender, Policy, Prevention, Stakeholders, Vaccination
Tags: 
gender issues, influenza, Vaccine, chronic diseases

WHO Guidelines on Ethical Issues in Public Health Surveillance

WHO. 2017. WHO Guidelines on Ethical Issues in Public Health Surveillance.

Target: 
Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Stakeholders
Tags: 
WHO, public health, ethical issues, guidelines
  • Read more about WHO Guidelines on Ethical Issues in Public Health Surveillance

Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial.

Pitisuttithum P, Boonnak K, Chamnanchanunt S, Puthavathana P, Luvira V, Lerdsamran H, et al. Lancet Infect Dis. 2017 Aug;17(8):833-842. 

Background: The emergence of highly pathogenic avian influenza H5N1 viruses has raised concerns about their pandemic potential. Vaccination is the most effective way of preventing influenza. In this study, we investigated the safety and immunogenicity of an avian H5N2 live attenuated influenza vaccine (LAIV H5N2) in healthy Thai adults and its priming immune responses with an H5N1 inactivated vaccine boost.

Target: 
Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Epidemiology, Vaccination
Tags: 
influenza, pandemic, influenza virus vaccine
  • Read more about Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial.

Vaccination communication strategies: What have we learned, and lost, in 200 years?

McKinnon M, Orthia LA.  JCOM. 2017;16(03),A08.

Target: 
Citizens, Decision Makers, Government and Public Health
Topic: 
Media, Stakeholders
Tags: 
Health communication, Science communication, vaccination campaigns, Vaccine hesitancy
  • Read more about Vaccination communication strategies: What have we learned, and lost, in 200 years?

Stopping emerging influenza viruses at their origin

Krammer F. Lancet Infect Dis. 2017 Aug;17(8):784-786.

Target: 
Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Epidemiology, Prevention, Vaccination
Tags: 
influenza, pandemic, influenza virus vaccine
  • Read more about Stopping emerging influenza viruses at their origin

Women and Asthma in the EU

European Institute of Women’s Health. October 2014.

Target: 
Decision Makers, Government and Public Health
Topic: 
Epidemiology, Gender, Policy
Tags: 
gender, asthma, policy, Pregnancy
  • Read more about Women and Asthma in the EU

Women and Diabetes in the EU

European Institute of Women’s Health. January 2013.

Target: 
Decision Makers, Government and Public Health
Topic: 
Epidemiology, Gender, Policy
Tags: 
gender, diabetes, cardivascular diseases, Pregnancy, policy
  • Read more about Women and Diabetes in the EU

Women and Cardiovascular Disease in the EU

European Institute of Women’s Health. February 2013.

Traditionally regarded as a male disease, cardiovascular disease (CVD) is the number one killer of women worldwide. It also is a major cause of serious illness and disability, costly to healthcare systems and destroying women’s quality of life. In the EU, CVD remains the top cause of death for women in each of the twenty-seven EU countries. Only during the last decades has awareness been rising how CVD affects women differently from men, alerting women to their risk. 

Target: 
Decision Makers, Government and Public Health
Topic: 
Epidemiology, Gender, Policy
Tags: 
gender, cardivascular diseases, Pregnancy, policy
  • Read more about Women and Cardiovascular Disease in the EU

Gender integration in Horizon 2020

Tuesday, June 20, 2017 - 09:04

Gender is considered a main issue in Horizon 2020, the largest ever EU Research and Innovation programme, with €80 billion worth of funding available over seven years. The European Commission has identified seven priority areas of societal challenges, with the goal targeting investment in research in these fields. They are:

  • Read more about Gender integration in Horizon 2020
Target: 
Decision Makers, Government and Public Health
Topic: 
Gender, Human Rights, Mutual Learning, Policy, Prevention, Stakeholders
Tags: 
gender, gender issues, science and society, clinical trials, Horizon 2020, research

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next ›
  • last »

Newsletters

Select the newsletter(s) to which you want to subscribe or unsubscribe.

News from Asset project
Responsible Research and Innovation Newsletter
Asset PPRB
E-mail *

Contacts

Facebook
Twitter
YouTube
LinkedIn

Contacts

General inquiries: info@asset-scienceinsociety.eu

ASSET

Action plan on Science in Society related issues in Epidemics and Total pandemics
European Commission
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 612236.

Source URL: https://www.asset-scienceinsociety.eu/target/decision-makers?page=3